Evidence map›Paper›PMID 41760871›Full record

ArticleJournal of religion and health2026

Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies.

Stephen P Lewis, Jaime Clark-Soles, Oriana Mayorga, Sarah K Sawyer, Eliza Slavet, B Jeffrey Vidt, Saundra Shanti, Rhiana Wiggins, Kathleen Willis, Jonathan Frey and 2 more

Abstract read
In one paragraph

Article in Journal of religion and health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stephen P LewisUniversity of California, San Diego, 200 West Arbor Drive, #8959, San Diego, CA, 92103, USA. s6lewis@health.ucsd.edu.ORCID http://orcid.org/0009-0007-0000-3630
Jaime Clark-SolesPerkins School of Theology, Southern Methodist University, Dallas, USA.ORCID http://orcid.org/0000-0002-4401-7512
Oriana MayorgaYale University, New Haven, USA.
Sarah K Sawyer, Boulder, USA.ORCID http://orcid.org/0009-0007-6554-9757
Eliza SlavetVitas Healthcare, San Diego, USA.ORCID http://orcid.org/0009-0000-1306-6736
B Jeffrey VidtChildren's Hospital of Eastern Ontario, Ottawa, Canada.ORCID http://orcid.org/0009-0002-0690-9541
Saundra Shanti, Salt Lake City, USA.
Rhiana Wiggins, Boulder, USA.ORCID http://orcid.org/0009-0008-3090-8366
Kathleen WillisHarvard Divinity School, Harvard University, Cambridge, USA.
Jonathan FreySharp HospiceCare, San Diego, USA.ORCID http://orcid.org/0009-0002-1135-3832
R Mark GraceBaylor Scott and White Health, Dallas, USA.ORCID http://orcid.org/0009-0005-4776-7051
Aaron D CherniakStockholm University, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-9114-4290

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid expansion of psychedelic research has opened significant pathways of opportunity in treating mental health disorders. Participants in recent clinical trials consistently report mystical-type experiences during dosing sessions, and some scholars posit that such experiences themselves help mediate clinical improvements in depression, PTSD, anxiety, and substance use disorders. These reports are in keeping with the historical reality that the use of psychedelic substances and plant medicine has been tied to spiritual experience and shamanic ceremonial practice. Professional clinical chaplains are trained and experienced in providing spiritual and emotional support for people encountering illness, life change, and trauma. They regularly assist participants who seek to make meaning of their experiences in the context of their own beliefs and spirituality. This article argues that as subject matter experts in spirituality and health, chaplains are an asset to psychedelic assisted therapies and should be utilized in research trials and clinical practice, especially given a relative lack of training in spirituality and religion among interprofessional practitioners. We offer this set of competencies for chaplains to provide high quality, safe, and ethical care in the context of psychedelic medicines. These competencies include spiritual and religious care, spiritual inquiry, empathic presence, ethical engagement, and advocacy. We recognize that chaplains will need to pursue specialized education and supervised experience beyond their standard professional requirements, and pathways of personal preparation are discussed. The presence of qualified chaplains will help ensure that participants navigate non-ordinary states of consciousness with safety, sensitivity, and insight regarding improvement and growth.

Indexed as

ClergyHallucinogensMental DisordersProfessional CompetenceHumansSpiritualityHallucinogensChaplainPsychedelic-assisted therapyPsychedelic clinical trialsPsychedelicsSpiritual care, mental health, psychedelic chaplaincySpiritual care providerSpiritual health practitioner

Identifiers

PMID41760871
PMCPMC13176024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.